Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panthenol and hydroxyasiaticoside repair cream for post-acne erythema
ChiCTR2600133194Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of panthenol and hydroxyasiaticoside in Postinflammatory erythema (PIE) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: PAHPI score. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
panthenolhydroxyasiaticoside
03
Conditions
Postinflammatory erythema (PIE)
Beyond the preview
Go deeper on ChiCTR2600133194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133194.